Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (4): 475-480.doi: 10.12092/j.issn.1009-2501.2023.04.016

Previous Articles     Next Articles

Research progress on the treatment of autism spectrum disorders based on gut microbiota intervention

ZHANG Qiang1, ZHENG Huajun2, LI Quan1   

  1. 1Department of Obstetrics and Gynecology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou, China; 2Institute of Infection and Immunity, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai 200032, China 
  • Received:2022-12-29 Revised:2023-03-06 Online:2023-04-26 Published:2023-05-17

Abstract:

Autism spectrum disorder is a set of neurodevelopmental disorders with unclear etiology and pathogenesis and no cure. Studies have found that the gut microbiota plays a vital role in the occurrence and development of autism spectrum disorder. By supplementing with probiotics, diet management or fecal microbial transplantation, the balance of gut microbiota can be adjusted to improve the behaviors and symptoms of patients with autism spectrum disorder. This article reviews from the perspective of regulating the bal- ance of gut microbiota to treat autism spectrum disorder, and aims to provide assistance for the re- search and treatment of autism spectrum disorder.

Key words: autism spectrum disorder, gut microbiota, probiotics, fecal microorganism transplantation, diet therapy

CLC Number: